Benzodiazepines Counteract Rostral Anterior Cingulate Cortex Activation Induced by Cholecystokinin-Tetrapeptide in Humans

  title={Benzodiazepines Counteract Rostral Anterior Cingulate Cortex Activation Induced by Cholecystokinin-Tetrapeptide in Humans},
  author={Gregor Leicht and Christoph Mulert and Daniela Eser and Philipp Gero S{\"a}mann and Matthias Ertl and Anna Laenger and Susanne Karch and Oliver Pogarell and Thomas Meindl and Michael Czisch and Rainer Rupprecht},
  journal={Biological Psychiatry},

Figures from this paper

Central amygdala circuit dynamics underlying the benzodiazepine anxiolytic effect
It is proposed that BZDs block the relay of aversive signals through the CEA, in part by local binding to CEAl SST + /PKCδ − neurons and reshaping intra-CEA circuit dynamics.
Acute Shift in Glutamate Concentrations Following Experimentally Induced Panic with Cholecystokinin Tetrapeptide—A 3T-MRS Study in Healthy Subjects
According to preclinical studies, glutamate has been implicated in the pathogenesis of anxiety. In order to elucidate the role of glutamate in anxiety and panic in humans, brain glutamate+glutamine
Cortical and subcortical gamma amino acid butyric acid deficits in anxiety and stress disorders: Clinical implications.
  • A. Goddard
  • Psychology, Biology
    World journal of psychiatry
  • 2016
Novel GABAergic pharmacotherapies in development offer potential improvements over current therapies in reducing sedative and physiologic dependency effects, while offering rapid anxiolysis.
New perspectives in neurosteroid action: open questions for future research
It is evident from many preclinical studies that neurosteroids modulate anxiety-related behavior but nevertheless many issues are far from being understood and a major issue of future research should be the elucidation of the mechanisms of action of neurosteroid both at the molecular, cellular and brain network level.
The ACC is a critical hub for neuropathic pain- induced depression
It is shown that the anterior cingulate cortex is a critical hub for neuropathic pain-induced depression, and a permanent lesion or temporal inhibition of ACC pyramidal neurons blocked the development or suppressed the expression of an anxiodepressive phenotype in neuropathic mice.
A Cognitive-Neuropsychological Account of Treatment Action in Anxiety: Can We Augment Clinical Efficacy?
Converging evidence suggests that both SSRI and CBT modulate cognitive bias and underlying functional abnormalities early during treatment, and that such changes moderate recovery from anxiety.
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition
  • B. Bandelow, D. Baldwin, P. Riederer
  • Psychology, Biology
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
  • 2017
Although at present, none of the putative biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD) is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve understanding of the neurobiological causes of anxiety disorders.
GABAergic modulation of conflict adaptation and response inhibition
Using a recently developed computational model to disentangle conflict adaptation and response inhibition, the results suggest that conflict adaptation is mediated by GABA-A neurotransmission.


Functional neuroanatomy of CCK‐4‐induced panic attacks in healthy volunteers
Overall brain activation patterns are not related to the subjective anxiety response to CCK‐4, but amygdala activation may be involved in the subjective perception of CCK•4‐induced fear.
One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: Investigation of neural correlates with BOLD MRI
One milligram of lorazepam was not sufficient to reverse strong panicogenic effects, but decreased brain activity in the case of mild anxiety, so as to not modify the anxiogenic and cardiovascular effects of CCK-4.
Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers.
Some of the temporopolar cortex CBF activation peaks previously reported in humans in association with drug- and non-drug-induced anxiety, as well as the increase in regional CBF in the claustrum-insular-amygdala region, may be of vascular and/or muscular origin.
Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing.
The current finding provides the first neuroimaging evidence of a dose-dependent change induced by an established therapeutic agent in brain regions known to be critical for the mediation of anxiety.
Effects of Alprazolam on Cholecystokinin-Tetrapeptide-Induced Panic and Hypothalamic–Pituitary–Adrenal-Axis Activity: A Placebo-Controlled Study
Alprazolam reduces CCK-4-induced panic, which supports the hypothesis of a possible interaction between the GABA and the CCK system and reduces the number of reported symptoms compared to placebo.
Vigabatrin Decreases Cholecystokinin-Tetrapeptide (CCK-4) Induced Panic in Healthy Volunteers
Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge
The current finding provides the first evidence of the modulatory effects of an established anxiolytic agent on brain activation related to anticipatory anxiety.